Henoch-Schonlein purpura is a relatively common pediatric vasculitis. Very few cases of Henoch-Schonlein purpura during pregnancy have been described. Henoch-Schonlein purpura is variable in its presentation, from completely benign to possibly catastrophic complications. This rarely encountered condition in adults can also be a recurrence of a previous childhood disease. We present a case of a pregnant 40-year-old woman with Henoch-Schonlein purpura, resulting in a viable birth with no fetal complications. Her presentation is discussed in detail and a general presentation of Henoch-Schonlein purpura is explored, with particular attention to its rare onset during pregnancy.
Introduction
Henoch-Schonlein purpura (HSP) is a relatively common pediatric vasculitis. Rare in adults, few cases of HSP during pregnancy have been described. With a continuum of severity from benign to catastrophic end-stage renal failure, this disease can affect both mother and fetus. We present a case of new-onset HSP during pregnancy and a clinical review of this challenging diagnosis.
Case
A primigravid, 40-year-old Algerian woman presented to the emergency department at 35 weeks of gestation because of a macular eruption around both ankles, with concomitant arthralgia of the neck, elbows, shoulders, and wrists.
Her pregnancy had been uneventful except for conceiving by in vitro fertilization. On examination, she appeared healthy and her blood pressure was 116/65 mmHg. The rash was noted to be palpable purpura, distributed bilaterally to the ankles and distal legs (Figure 1 ). Joint tenderness was present in both shoulders, elbows, wrists, and ankles, but no frank synovitis was documented. During the next 48 hours the eruption spread proximally and gained a more hemorrhagic appearance.
Laboratory work-up showed new-onset proteinuria with a urinary protein to creatinine ratio of 0.156 g/mmol (normal value: less than 0.040 g/mmol) and microscopic hematuria. Serum creatinine was slightly elevated as compared to earlier during her pregnancy at 62 mmol/l (normal value: 42-89 mmol/l). Complete blood count and hepatic parameters were within normal ranges. Antinuclear and antineutrophil cytoplasmic antibodies were negative and normal levels of C3 and C4 were noted. Infectious screening, including hepatitis B and C, CMV, EBV, parvovirus, and antistreptolysin O were negative. The C-reactive protein level was 67.4 mg/l. Initial fetal monitoring and obstetric ultrasound were normal. A skin biopsy was performed and showed leucocytoclastic vasculitis with significant immunoglobulin A (IgA) deposition. HSP was diagnosed.
Topical steroids were prescribed. Neither systemic steroids nor other immunosuppressive therapy were used because of the mild severity of her disease. One week later, the urinary protein to creatinine ratio spontaneously decreased to 0.076 g/mmol with no new purpuric lesions. Plasma creatinine decreased to its baseline at 44 mmol/L, while blood pressure remained normal. At 39 weeks of gestation, a healthy male infant was delivered by caesarean section due to delayed progression after labor induction. At follow-up three months post-partum, renal involvement had completely resolved.
Discussion
HSP is an acute small-vessel vasculitis that may occur at any age, but is usually a disease of childhood, with a mean age at presentation of six years.
1 Clinical manifestations result from IgA deposition in the vessel walls and renal mesangium.
1,2 Official criteria were developed to simplify diagnosis in adults (Table 1) . 3 HSP during pregnancy is rare: we identified only 22 cases of HSP in pregnant women between 1980 and 2015 using PubMed, including 13 de novo cases. Only two cases were identified in the first week post-partum. 4, 5 Our case is the first to be described in a woman over 40 years old.
HSP effect on pregnant women
HSP can affect pregnant women variably, depending on the organ involved. Cutaneous purpura is the essential clinical element for HSP diagnosis and all women in our review were affected. HSP is characterised by a palpable rash on the buttocks and lower extremities with coalescent ecchymoses without thrombocytopenia. Arthritis, occurring in 50 to 75% of pediatric patients, 1 was present in only 32% of pregnancies. Gastrointestinal involvement was described in 45% of this series. Renal involvement seems equally frequent in adults and children. 3, 6 Microscopic hematuria is the most common finding in children, but proteinuria was more prevalent than hematuria in pregnant women (29% vs. 19%). Usually nephritis becomes active after skin lesions form and patients can develop new urinary abnormalities during the six months following the purpura. 7 Most pregnant women did not receive immunosuppression, as only 27% of them received systemic corticosteroids during their illness. Almost all received topical corticosteroid. The prognosis is difficult to establish because of the limited numbers of published cases. Seven cases had significant complications. One case of eclampsia was reported after an initial diagnosis of indolent HSP at 24 weeks. 8 Two patients (9%) received plasma exchange. Two cases, following a diagnosis of new-onset HSP at 13 and 23 weeks, were complicated by severe renal failure with anasarca, hypertension, and oliguria that required renal replacement therapy. Fetal loss occurred at 25 weeks for one of them. 9, 10 HSP effect on the fetus Long-term effects on the fetus are unknown. In our review, two pregnancies ended with fetal losses at 16 and 25 weeks. 10, 11 Despite the small number of cases and a likely reporting bias, most pregnancies, including the patient in our case, had spontaneous recovery and viable infants. Fewer than half of the case reports stated birth weight and neonatal outcomes. The severity of renal involvement during pregnancy seems to be the most important determinant of fetal outcomes.
Effect of the pregnancy on HSP
For most patients, adults or children, HSP is limited in duration. It usually resolves spontaneously within four weeks without permanent complications, but recurrences can occur. A long-term follow-up study of children with HSP reported that 16 of 44 (36%) pregnancies over time were complicated by various levels of hypertension and proteinuria, 12 which is much more frequent than in the general population. In our review, 36% of cases were recurrences of a childhood HSP. Only one case was a recurrence after the onset of HSP during a previous pregnancy. 13 The limited number of cases in adults makes it impossible to determine if pregnancy itself is a risk factor for developing de novo HSP.
Treatment and management
The use of corticosteroids early in the course of HSP does not seem to impact the renal prognosis, but reduces gastrointestinal and joint symptoms and diminishes proteinuria levels in a pediatric randomized trial. 14 Moreover, the impact of corticosteroids has never been studied in an adult prospective trial. Other immunosuppressive treatments were described in some case reports to treat severe nephritis, and included pulsed corticosteroids, plasma exchange, azathioprine, and calcineurin inhibitors, with inconsistent results. 15 Renal biopsy is recommended in severe nephritis, because it can orient the treatment strategies according to the pathophysiology of renal HSP involvement. 16 In our review, 44% of women with severe renal involvement had had a renal biopsy in postpartum follow-up. No cases of biopsy during pregnancy for HSP were described in the literature. Finally, renal function of these patients should be followed up with regular creatinine measurement and urinalysis, although the required duration is not yet determined.
Conclusion
HSP is an uncommon disease that typically presents with cutaneous lesions, abdominal pain, arthralgia, and renal involvement. Rarely seen in adult, HSP is often a recurrence of a previous pediatric presentation. Recovery is generally spontaneous, but some patients may develop severe complications, most notably nephritis. The effects of HSP on pregnancy and vice versa remain unclear. Careful monitoring is usually appropriate if the renal involvement is mild. In this complicated disease, patient care should involve different medical specialties, including obstetric internists, maternal-fetal specialists, and nephrologists. 
